Literature DB >> 12926581

Preference-based measurement of health-related quality of life (HRQL) in children with chronic musculoskeletal disorders (MSKDs).

H I Brunner1, D Maker, B Grundland, N L Young, V Blanchette, A M Stain, B M Feldman.   

Abstract

BACKGROUND: Health-related quality of life can be measured by patients' health preferences (utilities or values). No method for measuring health state preferences has been standardized for children with arthritis or other musculoskeletal disorders (MSKDs). Such a method is needed for economic evaluations of current and new pediatric treatments.
OBJECTIVES: 1) To assess the feasibility of utility measurements in children with MSKDs, 2) to test the validity of the Health Utility Index (HUI) for these children, 3) to assess whether rating scale values can be mathematically converted into meaningful standard gamble (SG) utilities, and 4) to study whether parents can act as proxies for their children with respect to health state preferences.
METHODS: Eighty parents of children with MSKDs were consecutively sampled. Their children, if 8 years of age or older (n = 55), were studied concurrently. Utilities of current health states were obtained by using the SG and the HUI in random order. In addition, health state preferences were assessed using categorical and analog rating scales. Traditional nonutility measures of health status (the Childhood Health Assessment Questionnaire [CHAQ] and the Activities Scale for Kids [ASK]) were also completed. Intraclass correlation coefficients (ICCs) were calculated to assess concordance between the different utility measures and also between the ratings of the parents and their children.
RESULTS: Children 8 years of age or older were able to express the strength of their health state preferences using the HUI and rating scales. Children older than 10 years of age were able to use the SG method. The health state utilities of the parents were higher than those of their children. The utilities varied widely depending on the elicitation method. The expected high agreement between the SG and the HUI was not found (ICC = 0.028 for parents, ICC = 0.016 for patients). Unlike the SG, the global utilities derived from the HUI agreed better with preferences derived from rating scales (ICC = 0.23-0.25) and correlated with traditional health status measures (with CHAQ, r = -0.56; with ASK, r = 0.46) both for parents and children. It was not possible to mathematically convert rating scale preferences into SG utilities. The SG utilities were unrelated to results from the rating scales, the CHAQ, and the ASK. Especially for parents, the SG utilities were very high, even when ratings of the other measures indicated poor health.
CONCLUSIONS: Although it is possible to measure health utilities for children with MSKDs, the results are highly method dependent. The properties of the HUI in this population are more like those of the traditional health status measures rather than those of the SG. Preferences derived from rating scales, although easily performed, cannot readily be converted into SG utilities. Parents' ratings for their children are impaired by risk aversion.

Entities:  

Mesh:

Year:  2003        PMID: 12926581     DOI: 10.1177/0272989X03256008

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  26 in total

1.  Health values of patients coinfected with HIV/hepatitis C: are two viruses worse than one?

Authors:  Joseph M Mrus; Kenneth E Sherman; Anthony C Leonard; Susan N Sherman; Karen L Mandell; Joel Tsevat
Journal:  Med Care       Date:  2006-02       Impact factor: 2.983

Review 2.  Quality of life in children with systemic lupus erythematosus.

Authors:  L Nandini Moorthy; Margaret Peterson; Karen B Onel; Melanie J Harrison; Thomas J A Lehman
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

Review 3.  An emerging field of research: challenges in pediatric decision making.

Authors:  Ellen A Lipstein; William B Brinkman; Alexander G Fiks; Kristin S Hendrix; Jennifer Kryworuchko; Victoria A Miller; Lisa A Prosser; Wendy J Ungar; David Fox
Journal:  Med Decis Making       Date:  2014-08-21       Impact factor: 2.583

4.  Preferences for type 2 diabetes health states among adolescents with or at risk of type 2 diabetes mellitus.

Authors:  Erinn T Rhodes; Lisa A Prosser; Tracy A Lieu; Thomas J Songer; David S Ludwig; Lori M Laffel
Journal:  Pediatr Diabetes       Date:  2011-04-13       Impact factor: 4.866

5.  A qualitative analysis of a dyad approach to health-related quality of life measurement in children with asthma.

Authors:  Wendy J Ungar; Cara Mirabelli; Martha Cousins; Katherine M Boydell
Journal:  Soc Sci Med       Date:  2006-08-02       Impact factor: 4.634

6.  Challenges in health state valuation in paediatric economic evaluation: are QALYs contraindicated?

Authors:  Wendy J Ungar
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

7.  Issues in the measurement of quality of life in hemophilia.

Authors:  Brian M Feldman
Journal:  Rev Bras Hematol Hemoter       Date:  2013

8.  Determinants of quality of life in children with chronic somatic disease: pilot data from the GapS Questionnaire.

Authors:  Bryn D Webb; Maru Barrera; Joseph Beyene; Manuel Carcao; Denis Daneman; Irene Elliott; Grace W K Gong; Ilana J Halperin; Sarah Lord; Heather Melville; Unni G Narayanan; Sylvia Ota; Melinda Solomon; Lillian Sung; Nancy L Young; Mary Zachos; Brian M Feldman
Journal:  Qual Life Res       Date:  2012-03-30       Impact factor: 4.147

9.  A parent-child dyad approach to the assessment of health status and health-related quality of life in children with asthma.

Authors:  Wendy J Ungar; Katherine Boydell; Sharon Dell; Brian M Feldman; Deborah Marshall; Andrew Willan; James G Wright
Journal:  Pharmacoeconomics       Date:  2012-08-01       Impact factor: 4.981

Review 10.  Measuring quality of life in children with spinal muscular atrophy: a systematic literature review.

Authors:  Shalvaree Vaidya; Stefan Boes
Journal:  Qual Life Res       Date:  2018-07-24       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.